Skip to main content
Communications Biology logoLink to Communications Biology
. 2019 May 1;2:153. doi: 10.1038/s42003-019-0413-7

Human brain transcriptome analysis finds region- and subject-specific expression signatures of GABAAR subunits

Adolfo Sequeira 1,, Kevin Shen 2, Assaf Gottlieb 3, Agenor Limon 2,
PMCID: PMC6494906  PMID: 31069263

Abstract

Altered expression of GABA receptors (GABAARs) has been implicated in neurological and psychiatric disorders, but limited information about region-specific GABAAR subunit expression in healthy human brains, heteromeric assembly of major isoforms, and their collective organization across healthy individuals, are major roadblocks to understanding their role in non-physiological states. Here, by using microarray and RNA-Seq datasets—from single cell nuclei to global brain expression—from the Allen Institute, we find that transcriptional expression of GABAAR subunits is anatomically organized according to their neurodevelopmental origin. The data show a combination of complementary and mutually-exclusive expression patterns that delineate major isoforms, and which is highly stereotypical across brains from control donors. We summarize the region-specific signature of GABAR subunits per subject and its variability in a control population sample that can be used as a reference for remodeling changes during homeostatic rearrangements of GABAAR subunits after physiological, pharmacological or pathological challenges.

Subject terms: Ion channels in the nervous system, Microarrays


Adolfo Sequeira et al. report an analysis of GABA receptor subunit expression from single-cell and global transcriptome data generated by the Allen Institute. They find that GABA receptor subunit expression is spatially organized according to neurodevelopmental origin and generate a reference from the control population for future studies.

Introduction

Gamma-aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the adult central nervous system (CNS). Its actions are carried by the opening of anionic channels called GABAA receptors (GABAARs), which are also pharmacological targets for drugs like benzodiazepines, barbiturates, ethanol, and nootropics, among many others14. The kinetics, physiology, and pharmacology of pentameric GABAARs are largely determined by their subunit stoichiometry. With 19 genes coding for individual subunits [α(1-6), β(1-3), γ(1-3), ρ(1-3), δ, θ, ε and π], the possible number of heteropentameric combinations is quite large. However, studies in animal models have shown that only few combinations are present in native tissue, with some of them more abundant than others in a region-specific pattern13,5. Because of the fundamental role of GABAARs in the control of neural excitability, changes in expression of these receptors have been implicated in neurological and psychiatric disorders characterized by alterations of the excitation to inhibition balance (e.g., epilepsy, autism spectrum disorders, schizophrenia, and major depression)615. Most gene expression studies have compared individual GABAAR subunits between diseased and control brains leading to a great understanding of severe Mendelian disorders7,16; however, figuring out the role of individual subunits in multifactorial and complex brain diseases has been more challenging, and studying only a few subunits may not be sufficient. The heteropentameric nature of GABAARs suggests that pathological changes in one or more subunits may remodel the stoichiometry of GABAARs and consequently their functional and pharmacological properties. So far, the most available way to measure the expression of all subunits is by microarray or RNA sequencing (RNA-Seq) technologies. Here again, large gaps of information of the healthy brain still complicate the analysis of GABAARs in complex brain disorders. Among the major roadblocks to understanding alterations of GABAARs in diseased states are scattered information of region-specific GABAAR subunit expression in healthy human brains17,18, unknown heteromeric assembly of predominant regional isoforms1,19, and lack of information about typical heterogeneity in the collective organization of GABAARs across healthy individuals20. In an effort to address these three issues, we performed four levels of analysis using publicly available data. The first analysis used microarray datasets from the Allen Institute to delineate major relationships between GABAAR subunits across 111 brain structures in six healthy human brains21. This analysis featured a low number of subjects but was extensive and comprehensive in its anatomical coverage. For the second analysis, we used RNA-Seq data from the Aging, Dementia and Traumatic Brain Injury (ADTBI) study, which has a high number of subjects (n = 56) but is limited to four regions: the hippocampus, the temporal and parietal cortices, and the white matter of the forebrain. For the third and fourth analyses, we used the RNA-seq dataset from the Allen Institute cell type study (13,348 single-cell nuclei from the medial temporal gyrus (MTG) of two subjects) to determine the coexpression of subunits according to their major classes (excitatory vs inhibitory) and their cell types (24 excitatory neurons and 45 inhibitory neurons). Together, these analyses provide complementary views of the relationships between GABAAR subunits in control human brains across different layers of complexity. We found that patterns of expression of GABAAR subunits are topographically organized according to their ontogenic origin and show high consistency in brain regions characterized by recurrent, or repetitive, cytoarchitecture at the regional and substructural levels. In contrast, subcortical regions composing the limbic and hypothalamic axis systems, which are often affected in neurological and psychiatric disorders, show high differential enrichment of specific GABAAR subunits. Moreover, some GABAAR subunits consistently show complementary or mutually exclusive expression patterns across the brain that delineate major heteropentameric assemblies. We also present a method to summarize the expression of the 19 genes in one metric that quantifies the organizational layout of GABAAR subunits within brain areas per subject, allowing for the calculation of the variability in the collective expression of brain structures in population studies. The organizational layout of GABAAR subunits in physiological conditions should help in determining their regional changes and remodeling in pathological conditions, and guide pharmacological strategies that target specific brain regions and functions by modulating GABAARs highly enriched in regions of interest.

Results

Global and region-specific brain expression

For analysis of gene expression of GABAAR subunits in the whole brain, we selected the most representative probe for each gene (Supplementary Data 1) from the Allen Brain Atlas Microarray Study according to the flowchart in Supplementary Fig. 1. The brain was divided into major regions, structures, and substructures following the Allen Brain Atlas nomenclature (Supplementary Data 2). This analysis showed three major gene expression profiles. Genes with background or noise levels of expression (Log2 < 4) across the brain (ρ1−3, π); genes with low global expression but high region-specific expression (α6, θ, γ3, ε); and genes with high expression all across the brain (Fig. 1a and Table 1). Among the high-expression genes, those for α1, β2 and γ2 contributed up to 48% of the global gene expression for GABAARs across the brain in the microarray dataset. Meanwhile, genes for α2, δ, β3, γ1, α5, and β1 contributed up to 43% of the total expression and genes for α3 and α4 up to 4%. As a group, these 11 genes contributed for ≈95% of total mRNA coding for GABAARs in the human brain (Fig. 1a). The second group with high region-specific expression subunits is of particular interest for pharmacological targeting of function/regions of the brain as these GABAARs are expressed at particularly high levels in discrete areas of the brain (Table 1).

Fig. 1.

Fig. 1

Global and region-specific gene expression of GABAA receptor (GABAAR) subunits in the human brain. a Box plots of microarray gene expression of public available data from the Allen Brain Atlas (111 substructures per 6 subjects). The median is represented by the line within the box, and the first and third quartiles are represented by the ends of the box. The whiskers extend from each end of the box to the first or third quartile ±1.5 (interquartile range). Structures out of the whiskers are outliers and color coded according to the inset. The percentage shown is the proportional contribution (%) of each GABAAR subunit to the total expression in the brain. Total expression is the sum of the non-Log expression of the 19 genes across the 111 substructures in the brain. The general mean ± SD is 5.4 ± 3.2. b Two-way unsupervised Ward’s hierarchical clustering shows separation of major brain regions based on the Log2 gene expression; GABAARs subunits also clustered together according to their level of expression in each region (e.g., GABRA1, GABRB2, and GABRG2 are in the same cluster). Labels for brain substructures and ontogenic origin are colored as per the insets. FL frontal lobe, Ins insula, CgG cingulate gyrus, HiF hippocampal formation, PHG parahippocampal gyrus, OL occipital lobe, PL parietal lobe, TL temporal lobe, Amg amygdala, GP globus pallidus, Str striatum, Cl claustrum, Hy hypothalamus, SbT subthalamus, DT dorsal thalamus, VT ventral thalamus, MES mesencephalon, CbCx cerebellar cortex, CbN cerebellar nuclei, Bpons basal part of the pons, PTg pontine tegmentum, MY myelencephalon. For substructure abbreviations, please see Supplementary Table 2

Table 1.

Anatomical enrichment of the GABAARs subunits across the human brain

Subunit Major region Structure Structure abbreviation Substructure abbreviation Expression (Log2) Fold enrichment
GABRA1 Cerebral cortex Occipital lobe OL Cun-str 10.22 2.30
GABRA2 Cerebral nuclei Amygdala Amg LA 10.24 3.38
GABRA3 Cerebral cortex Hippocampal formation HiF CA1 7.98 3.68
GABRA4 Cerebral nuclei Striatum Str Acb 7.70 3.34
GABRA5 Cerebral cortex Hippocampal formation HiF CA2 10.09 10.21
GABRA6 Cerebellar cortex Cerebellar cortex CbCx PV-V 10.45 204.81
GABRB1 Cerebral nuclei Amygdala Amg CeA 8.85 2.73
GABRB2 Cerebral cortex Occipital lobe OL Cun-str 9.76 1.98
GABRB3 Cerebral cortex Hippocampal formation HiF DG 9.89 3.59
GABRD Cerebellar cortex Cerebellar cortex CbCx PV-VIIB 10.34 7.94
GABRE Hypothalamus Hypothalamus Hy PrOR 5.41 13.48
GABRG1 Cerebral nuclei Amygdala Amg CeA 11.27 10.47
GABRG2 Cerebral cortex Hippocampal formation HiF DG 10.63 2.05
GABRG3 Hypothalamus Hypothalamus Hy PrOR 4.26 2.37
GABRP Mesencephalon Mesencephalon MES RN 2.27 1.56
GABRQ Cerebral cortex Hippocampal formation HiF DG 7.34 31.41
GABRR1 Thalamus Dorsal thalamus DT ILr 2.45 2.05
GABRR2 Mesencephalon Mesencephalon MES RN 2.60 1.72
GABRR3 Myelencephalon Myelencephalon MY IO 3.20 1.44

The expression (Log2) represents the average expression per brain region and the fold enrichment the increase in the expression compared to the global average

CA1 CA1 field, Acb nucleus accumbens, CA2 CA2 field, PV-V V, paravermis, CeA central nucleus, Cun-str cuneus, striate, DG dentate gyrus, GABAAR GABAA receptor, PV-VIIB VIIB, paravermis, PrOR preoptic region, RN red nucleus, ILr rostral group of intralaminar nuclei, IO inferior olivary complex

The expression pattern of GABAAR subunits was relatively homogenous within the cerebral and cerebellar cortices (Fig. 1b). A more heterogeneous gene expression profile was observed within subnuclei of the hippocampal formation, amygdala, basal ganglia, pons, and myelencephalon (MY). More specifically, the hippocampal formation, amygdala, and hypothalamus contained substructures with the more region-specific expression of particular subunits (Table 1). For instance, the highest expression for the γ2, β3, and θ subunits was found in the dentate gyrus of the hippocampus. Similarly, the central nucleus of the amygdala had the largest expression of β1 and γ1, and the preoptic region of the hypothalamus expressed the most ε and γ3.

The cerebellar cortex had the highest expression of α6 and δ genes, and the nucleus accumbens in the striatum had the highest expression of the α4 subunit (Fig. 1b and Table 1). The highest enrichment of subunits within these substructures was for α6 in the fifth lobule of the paravermis (PV-V), with a 205-fold of overexpression compared to the average across the brain, followed by dentate gyrus (θ enriched by 31-fold), preoptic region (ε, 13-fold), and central amygdala (γ1, 10-fold). These regions with particular expression of GABAAR subunits might be pharmacologically targeted to modulate GABAergic neurotransmission in a region/function-specific way. Unsupervised hierarchical clustering (UHC) dendrograms, based on patterns of gene expression of the individual GABAAR, revealed that most major structures clustered according to their anatomical localization. Untransformed (non-Log2), transformed (Log2), and proportional contribution of each subunit (average percentage that each subunit represented over the sum of all 19 GABAARs subunits; Supplementary Fig. 2) per substructure data produced dendrograms that showed clear separation of four major clusters: the cerebral cortex and cerebral nuclei, the dorsal thalamus, and the cerebellar cortex, which originate from the telencephalon, diencephalon, and metencephalon, respectively (Fig. 1b and Supplementary Fig. 3)22,23.

The amygdala, striatum, and hippocampus, which are also of telencephalic origin, were clustered adjacently to each other and next to the cortical areas. The subiculum, which is in the transition zone between the hippocampus and the cerebral cortex and is categorized as part of the hippocampal formation, clustered with the lateral amygdala and claustrum. The results of the secondary clustering from both the quantum clustering (QC) and spectral co-clustering (SCC) methods display similar patterns to the hierarchical clustering (Fig. 2 and Supplementary Fig. 4). Specifically, the cerebellar cortex structures show the most robust clustering and are tightly clustered together mainly because of the high levels of expression of GABRA6. The next robust clustering was of the cerebral cortex followed by the clustering between hippocampus, amygdala, and striatum pairs. In addition, gene expression for ρ1, ρ2, and ρ3 were also robust across clustering methods and parameters and consistently clustered with the MY and ventral thalamus structures. Finally, gene expression for ε and θ were also co-clustered together.

Fig. 2.

Fig. 2

Quantum clustering secondary clustering of GABAA receptor (GABAAR) subunits across the brain. Colors denote the fraction of co-occurrence of two structures together across different scale parameters, transformed data (Log2 of gene expression), and proportional contribution (%) of each GABAAR subunit to the total mRNA pool in each substructure. Labels for brain substructures are colored as per the inset shown at the farthest right. FL frontal lobe, Ins insula, CgG cingulate gyrus, HiF hippocampal formation, PHG parahippocampal gyrus, OL occipital lobe, PL parietal lobe, TL temporal lobe, Amg amygdala, GP globus pallidus, Str striatum, Cl claustrum, Hy hypothalamus, SbT subthalamus, DT dorsal thalamus, VT ventral thalamus, MES mesencephalon, CbCx cerebellar cortex, CbN cerebellar nuclei, Bpons basal part of the pons, PTg pontine tegmentum, MY myelencephalon

Correlation of proportional contributions of GABAAR subunits

Most pentameric GABAARs are made up by the combination of at least three different subunits from different families in a 2:2:1 pattern (2α plus 2β and one of either: γ, δ, ε, or π); therefore, it is expected that the amount of proteins for subunits assembled in major GABAAR isoforms, and ubiquitously expressed in the brain, should be linearly correlated at the global brain level. Whether the same is true for mRNA is not known, though a high overlap between protein and mRNA expression levels has been observed for GABAARs2427. To investigate the patterns of collinearity between subunits across the brain, we first calculated the average percentage each subunit represented over the sum of all 19 GABAAR subunits expressed in each substructure for the 111 substructures analyzed (Fig. 3). This proportional contribution represents the available pool of GABAAR subunits mRNA in a particular brain region, structure, or substructure, and normalizes distinct levels of expression between different brain areas (e.g., cerebral cortex vs cerebral nuclei). Notably, many GABAAR subunits showed opposite patterns of expression. Opposite patterns between α1 vs α2, β1 vs β2 and γ1 vs γ2 are evident in Fig. 4 as mirror images of gene expression across the brain. Similar opposite patterns of expression were observed across the different brain areas of the ADTBI study (Supplementary Fig. 5) and across the 76 different cortical cell types from the cell-type Allen study (Supplementary Fig. 6).

Fig. 3.

Fig. 3

Region-specific proportional contribution of GABAA receptors (GABAARs) across the brain. Each colored band represents the average percentage of gene expression of each subunit to the total pool of GABAAR subunit in the brain (n = 6 subjects). y axis displays the contribution as percentage. x axis displays brain structures in rostro-caudal order, and color coded, according to the Allen Brain Atlas. Proportional contribution per substructure is the single percent value for each gene. FL frontal lobe, Ins insula, CgG cingulate gyrus, HiF hippocampal formation, PHG parahippocampal gyrus, OL occipital lobe, PL parietal lobe, TL temporal lobe, Amg amygdala, GP globus pallidus, Str striatum, Cl claustrum, Hy hypothalamus, SbT subthalamus, DT dorsal thalamus, VT ventral thalamus, MES mesencephalon, CbCx cerebellar cortex, CbN cerebellar nuclei, Bpons basal part of the pons, PTg pontine tegmentum, MY myelencephalon. For substructure abbreviations, please see Supplementary Table 2

Fig. 4.

Fig. 4

Global proportional contribution of gene expression by major subunit families. Mean ± SD of proportional contribution (%) of each subunit to the total pool of GABAA receptor subunits (n = 6 subjects). y axis displays proportional contribution as percentage. x axis displays brain structures in rostro-caudal order, and color coded, according to the Allen Brain Atlas. FL frontal lobe, Ins insula, CgG cingulate gyrus; HiF, hippocampal formation; PHG, parahippocampal gyrus; OL, occipital lobe; PL, Parietal lobe; TL, temporal lobe, Amg amygdala, GP globus pallidus, Str striatum, Cl claustrum, Hy hypothalamus, SbT subthalamus, DT dorsal thalamus, VT ventral thalamus, MES mesencephalon, CbCx cerebellar cortex, CbN cerebellar nuclei, Bpons basal part of the pons, PTg pontine tegmentum, MY myelencephalon. For substructure abbreviations, please see Supplementary Table 2

To better understand the relationships between GABAAR subunits, the 11 genes that contributed for ≈95% of total expression of GABAARs were chosen for correlation analyses. Strong positive and negative correlations between specific GABAAR subunits across the brain were clearly observed (Fig. 5a). The strongest positive correlation was between α1 and β2 (r = 0.76; p = 1.8e−22; n = 111 substructures, Supplementary Data 3), followed by between α2 and β3 and between α5 and β3, suggesting that these subunits are co-regulated and there is an increased probability that they may be present as pairs in the same receptors. Interestingly, strong negative correlations were observed between α3 and δ (r = −0.71; p = 2.3e−18) and between β1 and δ, as well as between β1 and β2, which are members of the same family (a comprehensive list of r and p values can be found in Supplementary Data 3). The δ subunit, which can substitute for either of the γ subunits, was negatively correlated with γ1 across the brain.

Fig. 5.

Fig. 5

Correlation analysis between the most expressed GABAA receptor subunits in microarrays and RNA-Seq. a Pearson correlations between the average of proportional contribution (%) of three genes that are significantly correlated across the brain using microarray datasets (n = 111 substructures; r and p values are shown as insets). b Same correlations using RNA-Seq datasets from the Aging, Dementia, and TBI study of the Allen Institute. N = 143 samples, 3 brain regions, from 52 subjects. c Linear correlations across distinct cell types using the mean of gene expression of all nuclei measured in each cell type (N = 12,560 nuclei), every dot is the mean of gene expression for each cell type. df Negative correlations using only nuclei in which the proportions of the three different components able to assemble in a pentameric receptor, Σα, Σβ, and Σχ, are close to a 2:2:1 proportions for all excitatory cells (d) or within distinct cell types (e, f)

Similar positive and negative correlations where observed when the temporal and parietal cortices and the white matter from the ADTBI were pooled together (Fig. 5b). Cross-correlation analysis of GABAAR subunits of the 3 brain regions (n = 143 samples from 50 subjects) showed strong positive correlations between subunits known to be assembled in native receptors (e.g., α1 and β2, r = 0.95; p = 2.2e−75; a comprehensive list of r and p values can be found in Supplementary Data 4). On the other hand, β1 and β2 subunits were negatively correlated (r = −0.97; p = 5.9e−88) as well as α1 with α2, β1, γ1; α2 with α4, β1, γ2; and γ1 with γ2. This indicated that the correlations between subunits were persistent at the global brain level and across a large number of subjects.

Because it might be possible that these correlations are not due to co-expression in the same cells but rather variability of cell types populations across brain areas, we analyzed RNA-Seq of the cell-type Allen Institute dataset. Single-cell nuclei data from this study had previously been classified in non-neuronal and neuronal cell classes28. Neuronal classes were classified in 24 glutamatergic and 45 GABAergic cell-type clusters based on their total gene expression (Supplementary Fig. 6). An initial PCA of the 19 GABAAR subunits for all 13,348 nuclei showed 2 highly overlapped populations that corresponded to excitatory and inhibitory neurons (Supplementary Fig. 7A). Further separation of excitatory vs inhibitory neurons was obtained when the mean of each gene per each of the 76 cell clusters was used for PCA (Supplementary Fig. 7B), indicating that the large variability in nuclei expression within each cell types hampers the collective analysis of GABAARs gene expression. Moreover, gene expression of GABAAR subunits in all cell-type clusters was extremely variable, with a large number of nuclei showing no expression of whole families of GABAAR subunits (Supplementary Fig. 8A).

To address this, we first analyzed the data within the context of the known pentameric structure of GABAARs and the complementary relationships found in this study (Fig. 4, Supplementary Figs. 5 and 6). Thus we determined the frequency distribution of three parameters: the sum of all GABRAx subunits (Σα = α1... + ...α6), the sum of all GABRBx + GABRQ subunits (Σβ = β1 + β2 + β3 + θ), and the sum of all subunits able to ensemble in the odd position (Σχ = γ1 + γ2 + γ3 + δ + ε + π), that are present in each nucleus. Remarkably, the means for Σα, Σβ, and Σχ were close to 40%, 40%, and 20%, respectively (Supplementary Fig. 8A), which correspond to the 2:2:1 proportions expected for pentameric GABAARs. Further analysis showed that the larger the number of nuclei sampled within each cell type the more Σα, Σβ, Σχ converge to 40%, 40%, and 20%, respectively (Supplementary Fig. 8B), indicating that most variability within each cell cluster is due to low number of nuclei sampling. Based on this information, for correlation analysis by cell-type clusters we only used datasets from nuclei in which the range of proportional contribution for Σα and Σβ was 40 ± 5% and for Σχ was 20 ± 5%. Remarkably, positive and negative correlations were consistently found when GABAAR subunits were correlated across different cell-type populations (Fig. 5c, Supplementary Data 5) or within each cell type (Fig. 5d–f and Supplementary Data 6). Interestingly, a strong negative correlation between GABRB2 and GABRB3 was evident at the single-cell level that was not observed when using whole-brain regions (complete list of the correlations can be found in Supplementary Data 5, 6, and 7). Table 2 shows the summary of all subunits pairs that were correlated in two or more of the analyses and are most likely shared (positive correlations), or mutually excluded from (negative correlations), the same receptor.

Table 2.

Pairwise correlation analysis of subunit gene expression across levels, from single cell to global brain expression

Positive correlations Negative correlations
Gene Gene Subunits From datasets Cell class (C,D) Gene Gene Subunits Cell class (C,D)
GABRA1 GABRB2 α1−β2 A,B,C,D Exc, 1 Inh GABRA1 GABRA2 α1, α2 B,C,D 9 Exc, 2 Inh
GABRA1 GABRD α1−δ B,D 1 Exc GABRA1 GABRA3 α1, α3 B,D 1 Exc
GABRA2 GABRA4 α2α4 A,C Exc, Inh GABRA1 GABRA4 α1, α4 C,D 4 Exc, 2 Inh
GABRA2 GABRB1 α2−β1 A,B GABRA1 GABRA5 α1, α5 D 2 Exc, 1 Inh
GABRA2 GABRB3 α2−β3 A,D 1 Inh GABRA1 GABRB1 α1, β1 A,B,C,D 1 Exc, 1 Inh
GABRA3 GABRB1 α3−β1 A,B,C,D 1 Exc GABRA1 GABRB3 α1, β3 A,C
GABRA4 GABRB2 α4−β2 B,D 1 Exc GABRA1 GABRG1 α1, γ1 A,B,C
GABRA4 GABRD α4−δ B,C Exc GABRA2 GABRA4 α2, α4 B,D 1 Exc
GABRB1 GABRB3 β1−β3 A,C Inh GABRA2 GABRB2 α2, β2 B,C,D 1 Exc, 1 Inh
GABRB1 GABRG1 β1−γ1 A,B GABRA2 GABRG2 α2, γ2 B,D 1 Inh
GABRA3 GABRD α3, δ A,B
GABRA5 GABRB2 α5, β2 B,C Inh
GABRA5 GABRG2 α5, γ2 B,C
GABRA5 GABRG2 α5, δ B,C
GABRB1 GABRB2 β1, β2 A,B,C,D 2 Exc, 4 Inh
GABRB1 GABRB3 β1, β3 D 2 Exc
GABRB1 GABRAD β1, δ A,B,C,D 1 Exc
GABRB2 GABRB3 β2, β3 D 11 Exc, 3 Inh
GABRB2 GABRG1 β2, γ1 A,B,C,D 1 Exc
GABRB3 GABRG2 β3, γ2 C,D 1 Inh
GABRG1 GABRG2 γ1, γ2 B,D 4 Exc
GABRG1 GABRD γ1, δ A,B
GABRG2 GABRD γ2, δ A,D 4 Exc, 3 Inh

Dataset A: Allen Atlas Microarray study, Dataset B: Aging, Dementia and Traumatic Brain Injury study, Datasets C and D: Allen Institute Cell-type study across excitatory and inhibitory cells and within each cell-type cluster, respectively. Cell class was determined from datasets C and D. Subunits in bold indicate pairs with positive and negative correlations across different analyses

Information in Table 2 supports the presence of human receptors with stoichiometries previously identified in animal models and listed by Olsen and Sieghart in 2008 (e.g., α1β2γ2, α4β2γ2, α4β2δ). It also supports the presence of receptors that are likely but have not been confirmed (e.g., α1β2δ and α2β1γ1). Additional evidence toward the existence of functional α2β1γ1 receptors in humans is provided by the observation that astrocytes only express genes for these three subunits (Supplementary Figure 6), and astrocytes are known to express functional GABAARs29. Perhaps the most interesting result is the identification of negative correlations between subunits. The presence of negative correlations across substructures with different cytoarchitectural make-up and distinct ontogenic origin, across different cell types, and across cells of the same type are strong indicators of potential mutual exclusion. Therefore, our analysis argues against the presence of receptors containing pairs of subunits listed in Table 2, particularly those that were observed as mutually exclusive in all four distinct analyses. For example, the existence of receptors with α1β1γ1 and α2β2γ1 stoichiometry or β1 and β2 in the same receptor is unlikely. Notice that β1−β3 had positive correlations in inhibitory cells but negative in two excitatory cell types; similarly, α2−α4 also showed positive and negative correlations, suggesting a cell-dependent modulation of these subunits.

Variability of collective organization across individuals

Potential variation between individuals may complicate our ability to generate a reliable reference map of GABAAR subunit expression in the human brain. Therefore, we used the Euclidean distances (d) between expression levels of each subunit to evaluate the extent of global organizational variation between individuals. First, inter-individual variability in the microarray cohort of the Allen Brain Atlas (n = 6 subjects) was quantified by calculating di (individual) and dc (consensus) between the expression levels of each subunit and correlating these results (Supplementary Fig. 9). The correlation coefficient (R) between the individuals and the consensus reference was high (R(di, dc) = 0.998 ± 0.0007; mean ± SEM)). Hierarchical clustering of the consensus data assists in visualizing associations between the different subunits (Fig. 6b). Two major conclusions can be made from the dendrogram. First, all subunits clustered on the right are highly expressed throughout the brain, and all subunits clustered on the left are expressed at noise levels except α6, ε, and θ, which have high expression only in specific brain regions (See also Fig. 1). Second, gene expression for α1, β2, and γ2 were clustered together and α2, β1, β3, and γ1 were closely associated. Hierarchical clustering of each subject (Fig. 6c) shows a high degree of variability in the relative positioning of each subunit and cluster but no variability in the clustering of the subunits themselves, particularly the α1, β2, and γ2 clusters.

Fig. 6.

Fig. 6

Global organizational layout of GABAA receptor (GABAAR) subunits. a Euclidean distance comparisons can be used to identify the organizational layout of GABAARs at different levels. b Dendrograms showing the whole-brain association between subunits at the group level (n = 6 subjects) using transformed (Log2) microarray data, notice the similarity with the subunits clustering in Fig. 1b. c Individual dendrograms showing the global association of subunits within each subject

Similar methods can be employed to determine the variability between individuals across brain areas at different anatomical levels (Fig. 6a). To compare the brain regions at the level of substructures the frontal operculum (Fro), which is the most frontal structure in the Allen Atlas, was chosen to construct a reference (consensus) against which all other 110 substructures were compared (dc,Fro). Each substructure from each subject was then measured against this reference (Fig. 7a). Minimal variability between individuals, as shown by high correlation values, was observed in frontal cortical areas, when using transformed (R(di, dc,Fro) = 0.985 ± 0.005) or proportional contribution data (R(di, dc,Fro) = 0.979 ± 0.007; Supplementary Fig. 10). Most cortical areas were similar to the reference and showed minimal inter-individual variability, except the occipital cortex, which was significantly different from the reference, and also was more variable between subjects (analysis of variance (ANOVA) results and p values are in Supplementary Data 8). We also compared brain areas at the structural level using the same approach (Fig. 7b; ANOVA results and p values are in Supplementary Data 8).

Fig. 7.

Fig. 7

Correlation coefficients of Euclidean distances as a metric of variability. a, b The Euclidean distances between subunits per structure per subject can be correlated against a standard (frontal operculum, fro) to show variability in subunit expression between substructures (a) or structures (b). Correlation coefficients (R) closer to one indicate higher similarity in expression patterns between the structure and the standard. Each dot is a single subject containing the information of the 19 GABAA receptor subunits. The box plots elements are defined as in Fig. 1. Brain regions are ordered in anteroposterior axis and color coded as in Fig. 1. c Euclidean distances from gene expression (fragments per kilobase of transcripts per million mapped read) and proportional contribution data from the ADTBI study were correlated against the parietal cortex. Again, coefficients closer to one indicate higher similarity between the structure and the parietal cortex. d, e Plots of proportional contribution against the correlation coefficients of the parietal cortex. Proportional contribution clearly shows opposite patterns between subunits. FL frontal lobe, Ins insula, CgG cingulate gyrus, HiF hippocampal formation, PHG parahippocampal gyrus, OL occipital lobe, PL parietal lobe, TL temporal lobe, Amg amygdala, GP globus pallidus, Str striatum, Cl claustrum, Hy hypothalamus, SbT subthalamus, DT dorsal thalamus, VT ventral thalamus, MES mesencephalon, CbCx cerebellar cortex, CbN cerebellar nuclei, Bpons basal part of the pons, PTg pontine tegmentum, MY myelencephalon. For substructure abbreviations, please see Supplementary Table 2

Clear differences in inter-structure heterogeneity and inter-individual variability are easily observed. For example, when compared to the reference, hippocampal regions were more heterogeneous and more variable between individuals (R(di, dc,Fro) = 0.85 ± 0.008) than the cerebral cortex but less than amygdalar nuclei or myelencephalic areas. The most distinct region from the neocortex was the cerebellar cortex (R(di, dc,Fro) = 0.36 ± 0.006), and the most heterogeneous and variable region between individuals was the MY. The remarkable minimal variation of the organizational layout of GABAARs between temporal and parietal cortex across control individuals, and its dissimilarity to hippocampus and white matter in terms of expression and variability across individuals, was confirmed using the parietal cortex as a reference (dc,PCx) in the RNA-Seq dataset of the ADTBI study (Fig. 7c). Hippocampus samples were the most variable across individuals (ANOVA results and p values are in Supplementary Data 9). The variability was explained by differences in the coordinated expression of GABAARs subunits. The closer R(di, dc,PCx) is to 1, the larger the expression of the subunits α1 and β2 and the lower the expression of α2, α5, β1, and β3 (Fig. 7d, e).

Discussion

Our multiple clustering analyses indicate that gene co-expression patterns of GABAAR subunits are region-specific and cluster according to embryonic structures. This suggests that co-expression patterns are determined early during development and relatively stable during adulthood within structures characterized by recurrent cytoarchitecture, like the cerebral and cerebellar cortices22. On the contrary, subcortical structures are more heterogeneous indicating greater diversity in inhibitory signaling processing, which is congruent with a more complex neuroanatomical cytoarchitecture. This heterogeneity also emphasizes the differential modulatory effects that the diverse subcortical nuclei have on the activity of distinct cortical regions30,31. A detailed characterization of the GABAARs patterns using functional rather than anatomical organizational principles will surely provide additional information in future studies.

Our observation of GABAARs expression patterns in brain regions clustered based on their embryonic origins is in agreement with previous studies which have shown that a large number of genes have a region-specific expression closely following their embryonic origin32,33. It is also congruent with the early role of GABAARs in the modulation of cell division, migration, and differentiation3436 and later with their participation in the generation of electrical and synaptic activity in developing neurons37,38. Expression patterns of GABAARs change during development18,39; however, the related patterns of GABAAR subunits expression of substructures within the amygdala, hippocampus, and striatum indicate that control mechanisms of phenotypic expression are partially shared among most telencephalic structures and partly differentiated into nuclei-specific patterns. A shared pattern may arise from a common embryonic structure, like the telencephalic interneurons that migrate from the ganglionic eminence to cortical areas4044, and further nuclei-specific differentiation is likely due to distinct developmental gene expression programs4547 and activity-dependent cell specification48,49. Although to our knowledge the molecular determinants of GABAAR subunits expression in humans are still not known, elegant work by Mulligan et al.50 identified several gene candidates in mice models that may participate in the coordinated expression of multiple subunits. Future research about human homologs of those candidates and their role in the developmental specificity of GABAARs is needed.

There was a large overlap between the expression of GABAARs in humans with accumulated evidence from animal models; however, there were also several important differences. Similar to previous observations in animal models and meta-analytical studies, the most abundant GABAAR mRNA subunits in the cerebral cortex were α1, α2, β2, and γ2. Positive correlations between these subunits indicate that heteromeric receptors composed of α1β2γ2 subunits are the most abundant across the cerebral cortex1,2,5053. Interestingly, α1 was negatively correlated with β1 and γ1 across the brain, suggesting a mutually exclusive relationship. Similarly, negative correlations suggest mutual exclusion between α1 and α2 and between β1 and β2. The mutual exclusion between α1 and α2 subunits is at odds with co-immunoprecipitation data from animal models. Although the majority of GABAARs receptors have one type of α subunit54, there are evidence of receptors containing both α1 and α2 subunits5456. Owing to limited human tissue availability, to our knowledge no similar data currently exists for humans; however, opposite expression of α1 and α2 in the different substructures of the hippocampus, thalamus, and substantia nigra are also clearly observed in recent immunohistochemical studies17,57,58. Although the presence of GABAARs with a1 -a2 stoichiometry in humans cannot be discarded, their presence might be limited; if they do occur it may be due to posttranslational mechanisms. In the cerebellar cortex, our correlation analysis strongly suggests the presence of native pentameric stoichiometries α6β2δ, α1β2δ, and α1β2γ2. Similarly, the presence of α5β3 pairs is expected in the hippocampus, and because α5 and δ are negatively correlated, the most probable combination of α5-GABAARs is α5β3γ2. Interestingly, the dentate gyrus has the highest gene expression of the θ subunit, an important difference with animal models. This subunit was highly correlated with α1, δ, and γ2, suggesting the presence of receptors with α1θγ2 or α1θδ stoichiometry. Alternatively, it is tempting to speculate that θ could replace one β2 or β3 subunit and make up receptors with α1β2/3θγ2 stoichiometry. With the exception of the dentate gyrus, the expression of θ subunit in humans shows a striking overlap with the adult rodent brain and is highly correlated with expression of α3 and ε (Fig. 1b)5961. The amygdala was the second most dissimilar brain region compared to the rest of the brain and expressed high levels of α2, β1, γ1, and ε, suggesting the presence of α2β1θε and α2β1θγ1 receptors. The preoptic region of the hypothalamus was the third most dissimilar expressing high levels of ε and γ3 subunits. Interestingly, the three most dissimilar structures according to GABAAR expression: dentate gyrus, central amygdala, and preoptic region, are also sites of adult neurogenesis in animal models62,63, which has been proposed as a mechanism of action of tricyclic antidepressants and selective serotonin reuptake inhibitors in these brain regions64. Moreover, the hippocampus, amygdala, and hypothalamus form part of two of the most critical networks in the brain, the limbic system, and the hypothalamic–pituitary–adrenocortical axis, often involved in neurologic and psychiatric disorders6567. The fold enrichment of unique subunits in these regions (Table 1) makes them particularly interesting pharmacological targets to regulate nuclei activity via modulation of GABAergic neurotransmission. However, it is important to recognize that GABAARs have a large range of pharmacological interactions and most GABAergic drugs have shared effects on different GABAARs (Supplementary Fig. 11). Moreover, many GABAergic drugs are subunit selective only in a very narrow nM range before affecting a broad range of GABAARs subtypes19. Thus the development of drugs with specificity on subunits differentially enriched requires further development. For example, drugs with selectivity over the θ subunits are limited despite the large abundance of θ on regions with strong neurogenesis, such as the dentate gyrus. A promising example of targeted pharmacology is the efficacy of inverse agonists of α5-containing GABAARs in the hippocampus that reduce memory impairment following alcohol consumption68.

Noise-level expression of transcripts for ρ1, ρ2, and ρ3 across the brain in microarray datasets is consistent with studies reporting a limited and cell-specific expression for these genes in animal models25,6972. Transcripts for π were at noise levels in microarray datasets and extremely low, if any, in RNA-Seq of the hippocampus and the temporal lobe. Although transcripts for π had been found in hippocampus and temporal cortex of humans73, little information about its distribution in the CNS is available, despite being identified as a susceptibility gene in schizophrenia74.

How are particular assemblies of GABAARs preferred over the many possibilities? Our correlation analysis argues in favor of a co-regulation of GABAAR subunits that are clustered in the same chromosome for the most abundant receptors in the brain (cis effects20), with a tight control by cell-specific transcription factors as seen in the temporal silencing of α6 in cerebellar granular cells75 or intrinsic signals that ensure mutual segregation76. Additional diversity of GABAARs across the brain is provided by coordinate transcription between genes located in different chromosomes (trans effects) similar to what is observed in mice50. Strong cis coordinated expression of subunits across brain regions suggest that remodeling of GABAARs during disease may happen within restricted and coordinated patterns. Evidence of this has been seen in alcohol and cocaine exposure20,77, Angelman syndrome78, and Alzheimer’s disease27, in which alterations of several subunits that are expressed in single chromosome clusters are collectively modified.

Probably the highest roadblock in comparing physiological and non-physiological brain states is the lack of information about whether the expression of GABAARs is stereotypical or highly variable across control individuals. Our results using Pearson correlation of Euclidean distances indicate that, despite high variation on the level of gene expression of individual subunits across control subjects, the collective organization of GABAARs in each brain structure is highly stereotypical, providing a framework for future studies exploring remodeling during diseased states. The combination of Euclidean distances and the proportional contribution of GABAAR subunits allows the quantification of population (cohort) variability, while identifying the subunits driving the variability.

The use of raw Euclidean distances to correlate pairs of GABAAR subunits in each region, across individuals, has some limitations that are common to other mathematical distances of the Minkoski family; for example, the large-scale feature dominates the rest79. However, this is a starting point from where we attempt to minimize the transformation of the data as much as possible. Moreover, the degree of dissimilarity is given by the correlation coefficient between the Euclidean distances of consistent sets of 19 gene values across subjects, and the lower the correlation coefficient, the larger is the extent of collective differences in subunit expression. Future studies focusing in evaluating distinct metrics of similarity and dissimilarity and correlation strategies80 for subunits of GABAARs and other neurotransmitter receptors across individuals are highly encouraged.

In conclusion, we show that the patterns of expression of GABAARs subunits in the brain is highly stereotypical across healthy controls. This consistent pattern within structures is observed even in regions with the highest intra-individual and intra-structure variation, like the hippocampus, amygdala, and hypothalamus. These regions are the most dissimilar to the rest of the brain and also show the most region-specific expression of GABAARs, underlining the opportunity to target specific regions to modulate GABA neurotransmission for precise pharmacological treatments targeting specific neuropsychiatric conditions. Future studies that include neurodegenerative and psychiatric RNA-Seq datasets should be useful to explore homeostatic rearrangements of GABAAR subunits after physiological, pharmacological, or pathological challenges.

Methods

Microarray and RNA-Seq databases

Three datasets, derived from public domain resources as described below, were used for this study: normalized microarrays from the Allen Brain Atlas at the sample resolution level (http://human.brain-map.org), normalized RNA-Seq datasets from gray matter (parietal cortex, temporal cortex, and hippocampus) and white matter of the forebrain from the ADTBI study (http://aging.brain-map.org/download/index), and normalized single-cell nuclei RNA-Seq datasets from the cell-type Allen study (http://celltypes.brain-map.org/rnaseq). For the microarray datasets, the detailed demographic characteristics of the 6 subjects (5 males and 1 female between 24 and 57 years of age with no known neuropsychiatric or neuropathological history), as well as technical white papers about tissue acquisition, data processing, normalization, and quality control procedures can be found at: http://help.brain-map.org/display/humanbrain/Documentation. For the RNA-Seq datasets of the ADTBI study, the demographic characteristics of 56 healthy controls (35 males and 21 females between 78 and 99 years of age with no history of neurodegenerative or psychiatric disorders) are also available in the downloading site. For single-cell analysis, we used an RNA-Seq dataset from two subjects, H200.1030 (54 year old, male) and H200.1023 (43 year old, female), that provided 84.8% of all data in the study. In total, 12,560 of neurons NeuN(+) (94.1%) and non-neuronal 788 NeuN(−) (5.9%) nuclei, from the 6 different cortical layers from these two subjects, were used for the initial analyses (Supplementary Figs. 2, 6, 7, and 8), and a subset of this cohort was used for the correlation analysis in Fig. 5 and Table 2.

Institutional Review Board review and approval was obtained for collection of tissue and non-identifying case information at the tissue banks and repositories that provided tissue to the Allen Atlas Institute; tissue was collected after informed consent from decendent’s next-of-kin (http://help.brain-map.org/display/humanbrain/Documentation). A diagram of the analysis flow and its relevance in the context of the study can be found in supplementary material (Supplementary Fig. 1).

Selection of microarray probes

The Allen Brain Atlas used 246 probes to measure the expression of 19 GABAARs genes (e.g., 49 probes to test GABRA1) using a custom design (by Beckman Coulter Genomics) Agilent 8 × 60K array that includes the 4 × 44K Agilent Whole Human Genome probe set supplemented with an additional 16,000 probes. To avoid redundant clustering due to the co-linearity between probes for the same gene, only one probe per gene was selected. For genes with only two probes, the probe with the highest expression was used. When more than two probes per gene were available, a principal components-based Exploratory Factor Analysis with no rotation in JMP 12Pro identified the most representative probe (Supplementary Data 1). Selected probes were also consistent across human subjects using the method described by Kirsch and Checnik33, wherein the expression correlation across regions of each probe was computed, then the correlation scores across all pairs of subjects were averaged, and the most correlative probe was chosen. Selected probes mapped to most of the splices variants for each gene in Ensembl genome browser (https://useast.ensembl.org/index.html), indicating no specific bias, and that our results are more representative of the collective isoforms expressed for each gene. This is strengthened by the observation that the similarities in the proportional contribution of each selected probe to the total pool of GABAARs in the temporal cortex was highly correlated to the RNA-Seq gene expression patterns in the temporal lobe of ADTBI study and the MTG of the cell-type Allen study (Supplementary Fig. 2), thus validating the selection of representative gene probes in the microarray study. For descriptive analysis, the brain was divided into major regions, structures, and substructures (Supplementary Data 2) using information from the Allen Brain Atlas. Only substructures that were measured across all 6 subjects, except the white matter in microarray datasets, due to negligible expression, were included in this study.

Analysis of data

Age effects on the levels of gene expression were corrected by linear regression in JMP version 14 discovery from SAS (JMP 14) using age as a continuous variable in the microarray datasets or as an ordinal value in the aging categories available in the ADTBI dataset. Sex and ethnicity had no effects on the mRNA expression levels in microarray or RNA-Seq datasets. For global expression in microarray analyses, the mean (M) ± standard deviation (SD) of GABAAR subunit expression for each structure, per subject, was calculated as the average of each substructure measurement, including left and right substructures, reported in the Allen Brain Atlas, unless stated otherwise. The proportional contribution of the total expression of each GABAAR subunit (Fig. 1a) was defined as the percentage of untransformed (non-Log2) expression level of each subunit to the total microarray expression of all GABAAR subunits across the brain, all of which add to 100%; the percentage of total expression of GABAAR subunits in the brain is equivalent to the area of one colored band in Fig. 3. The proportional contribution of each GABAAR subunit per substructure, or cell type, is the percentage of expression level of each subunit gene to the total pool of subunit genes within each brain substructure/cell type27,81. For this, the sum of non-Log2 microarray data, or fragments per kilobase of transcripts per million mapped reads in RNA-Seq data, of all 19 genes per substructure/cell type was 100%.

Clustering analyses

UHC was done using the Ward’s minimum variance method, where the distance between two clusters is the ANOVA sum of squares between the two clusters added up over all the variables. Ward’s method joins clusters to maximize the likelihood at each level of the hierarchy (JMP 14). We also used two additional clustering methods to assess the robustness of our clusters: QC82 and SCC83.

QC is based on physical intuition derived from quantum mechanics. It starts by constructing scale-space probability function from the data points and derives a potential function by viewing the latter as the lowest eigenstate of a Schrodinger equation. QC requires only one parameter, which determines the scale over which cluster structures are searched. Looking at clustering results at different scales enables the identification of robust clusters. Furthermore, it has been recently shown that QC has the advantage of an unbiased analysis by filtering out the weight information from the density function, while focusing on the shape of the data, thus allowing of detection of clusters of different densities84. Prior to applying QC, we preprocessed the data by taking only the top five principal components of the singular value decomposition (accounting for >80% of the variability of the data) and applying a whitening transformation. SCC, on the other hand, aims to identify biclusters of structures and GABA subunits. SCC requires the specification of the number of biclusters. In order to utilize both the QC scale parameter and the SCC cluster number parameters, we conducted a secondary clustering in which we varied these parameters over a large set of scales and cluster numbers and computed the percentage of times any two structures or GABA subunits in SCC co-appear in the same cluster.

Euclidean distances analyses

Pearson product–moment was used for all the linear correlations. To estimate the population variation of GABAAR transcriptional organization between subjects, we used the coefficient of correlation (R) between the Euclidean distances (di) of expression levels for the 19 subunits per each subject and the consensus Euclidean distances (dc) composed by all subjects. The Euclidean distances di and dc were calculated as shown below:

di(GABRx-GABRy)=(GABRx-GABRy)2 1
dc(GABRx-GABRy)=(GABRx1-GABRy1)2+(GABRx2-GABRy2)2++(GABRxn-GABRyn)2 2

where di is the Euclidean distance of a pair of subunits in each individual; x and y indicate distinct GABAAR subunits; dc is the consensus Euclidean distance; and n is the number of subjects in the group.

Statistics and reproducibility

Data analyses and plotting were initially implemented in JMP 14 and then repeated in RStudio using R3.5.0 and the mosaic package for R Markdown with the same results. QC and SCC were implemented as a custom code of published algorithms using Matlab version 9.1.10. Unbiased QC and SCC provide similar results to UHC. For statistical comparison of brain substructures in Euclidean distance analysis, we used one-way ANOVA followed by multiple comparison with the consensus using Dunnet’s method; p < 0.05 was considered significant.

Reporting summary

Further information on research design is available in the Nature Research Reporting Summary linked to this article.

Supplementary information

Supplementary Data 1 (10.5KB, xlsx)
Supplementary Data 2 (14.5KB, xlsx)
Supplementary Data 3 (18.3KB, xlsx)
Supplementary Data 4 (19.9KB, xlsx)
Supplementary Data 5 (18.5KB, xlsx)
Supplementary Data 6 (108.8KB, xlsx)
Supplementary Data 7 (14.9KB, xlsx)
Supplementary Data 8 (47.9KB, xlsx)
Supplementary Data 9 (11.4KB, xlsx)
Supplementary Data 10 (3.8MB, xlsx)
42003_2019_413_MOESM11_ESM.pdf (71.6KB, pdf)

Description of Additional Supplementary Files

Supplementary Material (3.3MB, pdf)
Reporting Summary (69.5KB, pdf)

Acknowledgements

The authors thank Dr. N. C. Spitzer, Dr. M. P. Vawter, and Dr. B. E. Hjelm for their insightful discussions of the manuscript. This work was supported by NIH research grants R01MH097082 (to A.S.), R21MH113177 (to A.L.), and R21AG053740 (to A.L.).

Author contributions

A.P.S., K.S., A.G., and A.L. contributed to the data analysis and writing of the paper. K.S. implemented the analysis in R. A.G. implemented SCC and QC analysis. A.P.S. contributed to the project design. A. L. conceived the project and contributed to its design.

Data availability

Microarray and RNA sequence data that support the findings of this study are available from the Allen Institute: http://human.brain-map.org, http://aging.brain-map.org/download/index, and http://celltypes.brain-map.org/rnaseq. Additional data used for the figures are provided in Supplementary Data 10.

Code availability

All codes used in this work have been previously published and are publicly available. A pipeline of the analysis for fast implementation can be provided upon request.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Adolfo Sequeira, Email: psequeir@uci.edu.

Agenor Limon, Email: aglimonr@utmb.edu.

Supplementary information

Supplementary information accompanies this paper at 10.1038/s42003-019-0413-7.

References

  • 1.Olsen RW, Sieghart W. International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update. Pharmacol. Rev. 2008;60:243–260. doi: 10.1124/pr.108.00505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Olsen RW, Sieghart W. GABA A receptors: subtypes provide diversity of function and pharmacology. Neuropharmacology. 2009;56:141–148. doi: 10.1016/j.neuropharm.2008.07.045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Sigel E, Steinmann ME. Structure, function, and modulation of GABA(A) receptors. J. Biol. Chem. 2012;287:40224–40231. doi: 10.1074/jbc.R112.386664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Limon A, Reyes-Ruiz JM, Miledi R. GABAergic drugs and Alzheimer’s disease. Future Med. Chem. 2011;3:149–153. doi: 10.4155/fmc.10.291. [DOI] [PubMed] [Google Scholar]
  • 5.Chua HC, Chebib M. GABAA receptors and the diversity in their structure and pharmacology. Adv. Pharmacol. 2017;79:1–34. doi: 10.1016/bs.apha.2017.03.003. [DOI] [PubMed] [Google Scholar]
  • 6.Kaila K, Ruusuvuori E, Seja P, Voipio J, Puskarjov M. GABA actions and ionic plasticity in epilepsy. Curr. Opin. Neurobiol. 2014;26:34–41. doi: 10.1016/j.conb.2013.11.004. [DOI] [PubMed] [Google Scholar]
  • 7.Wallace RH, et al. Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures. Nat. Genet. 2001;28:49–52. doi: 10.1038/ng0501-49. [DOI] [PubMed] [Google Scholar]
  • 8.Brooks-Kayal AR, Shumate MD, Jin H, Rikhter TY, Coulter DA. Selective changes in single cell GABA(A) receptor subunit expression and function in temporal lobe epilepsy. Nat. Med. 1998;4:1166–1172. doi: 10.1038/2661. [DOI] [PubMed] [Google Scholar]
  • 9.Fatemi SH, Folsom TD. GABA receptor subunit distribution and FMRP-mGluR5 signaling abnormalities in the cerebellum of subjects with schizophrenia, mood disorders, and autism. Schizophr. Res. 2015;167:42–56. doi: 10.1016/j.schres.2014.10.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Beneyto M, Abbott A, Hashimoto T, Lewis DA. Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia. Cereb. Cortex. 2011;21:999–1011. doi: 10.1093/cercor/bhq169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Beneyto M, Lewis DA. Insights into the neurodevelopmental origin of schizophrenia from postmortem studies of prefrontal cortical circuitry. Int. J. Dev. Neurosci. 2011;29:295–304. doi: 10.1016/j.ijdevneu.2010.08.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Sequeira A, et al. Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression. PLoS ONE. 2009;4:e6585. doi: 10.1371/journal.pone.0006585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Klempan TA, et al. Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression. Mol. Psychiatry. 2009;14:175–189. doi: 10.1038/sj.mp.4002110. [DOI] [PubMed] [Google Scholar]
  • 14.Braat S, Kooy RF. The GABAA receptor as a therapeutic target for neurodevelopmental disorders. Neuron. 2015;86:1119–1130. doi: 10.1016/j.neuron.2015.03.042. [DOI] [PubMed] [Google Scholar]
  • 15.Fatemi SH, Folsom TD, Rooney RJ, Thuras PD. Expression of GABAA alpha2-, beta1- and epsilon-receptors are altered significantly in the lateral cerebellum of subjects with schizophrenia, major depression and bipolar disorder. Transl. Psychiatry. 2013;3:e303. doi: 10.1038/tp.2013.64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Ishii A, et al. A de novo missense mutation of GABRB2 causes early myoclonic encephalopathy. J. Med. Genet. 2017;54:202–211. doi: 10.1136/jmedgenet-2016-104083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Stefanits H, et al. GABAA receptor subunits in the human amygdala and hippocampus: Immunohistochemical distribution of 7 subunits. J. Comp. Neurol. 2018;526:324–348. doi: 10.1002/cne.24337. [DOI] [PubMed] [Google Scholar]
  • 18.Stojanovic T, et al. Thealpha1, alpha2, alpha3, and gamma2 subunits of GABAA receptors show characteristic spatial and temporal expression patterns in rhombencephalic structures during normal human brain development. J. Comp. Neurol. 2016;524:1805–1824. doi: 10.1002/cne.23923. [DOI] [PubMed] [Google Scholar]
  • 19.Sieghart W, Savic MM. International Union of Basic and Clinical Pharmacology. CVI: GABAA receptor subtype- and function-selective ligands: key issues in translation to humans. Pharmacol. Rev. 2018;70:836–878. doi: 10.1124/pr.117.014449. [DOI] [PubMed] [Google Scholar]
  • 20.Enoch MA, Baghal B, Yuan Q, Goldman D. A factor analysis of global GABAergic gene expression in human brain identifies specificity in response to chronic alcohol and cocaine exposure. PLoS ONE. 2013;8:e64014. doi: 10.1371/journal.pone.0064014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Hawrylycz MJ, et al. An anatomically comprehensive atlas of the adult human brain transcriptome. Nature. 2012;489:391–399. doi: 10.1038/nature11405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Nieuwenhuys, R., Voogd, R. & van Huijzen, C. The Human Central Nervous System: A Synopsis and Atlas (Steinkopff-Verlag Heidelberg, Heidelberg, 1988).
  • 23.Dekaban A. Human thalamus; an anatomical, developmental and pathological study. II. Development of the human thalamic nuclei. J. Comp. Neurol. 1954;100:63–97. doi: 10.1002/cne.901000105. [DOI] [PubMed] [Google Scholar]
  • 24.Hortnagl H, et al. Patterns of mRNA and protein expression for 12 GABAA receptor subunits in the mouse brain. Neuroscience. 2013;236:345–372. doi: 10.1016/j.neuroscience.2013.01.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Rosas-Arellano A, Machuca-Parra AI, Reyes-Haro D, Miledi R, Martinez-Torres A. Expression of GABArho receptors in the neostriatum: localization in aspiny, medium spiny neurons and GFAP-positive cells. J. Neurochem. 2012;122:900–910. doi: 10.1111/j.1471-4159.2011.07621.x. [DOI] [PubMed] [Google Scholar]
  • 26.Fatemi SH, et al. mRNA and protein levels for GABAAalpha4, alpha5, beta1 and GABABR1 receptors are altered in brains from subjects with autism. J. Autism Dev. Disord. 2010;40:743–750. doi: 10.1007/s10803-009-0924-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Limon A, Reyes-Ruiz JM, Miledi R. Loss of functional GABAA receptors in the Alzheimer diseased brain. Proc. Natl. Acad. Sci. 2012;109:10071–10076. doi: 10.1073/pnas.1204606109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Hodge R, et al. Conserved cell types with divergent features between human and mouse cortex. BioRxiv. 2018 doi: 10.1101/384826. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Fraser DD, et al. GABAA/benzodiazepine receptors in acutely isolated hippocampal astrocytes. J. Neurosci. 1995;15:2720–2732. doi: 10.1523/JNEUROSCI.15-04-02720.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Saunders A, et al. A direct GABAergic output from the basal ganglia to frontal cortex. Nature. 2015;521:85–89. doi: 10.1038/nature14179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Sherman SM. Thalamus plays a central role in ongoing cortical functioning. Nat. Neurosci. 2016;19:533–541. doi: 10.1038/nn.4269. [DOI] [PubMed] [Google Scholar]
  • 32.Zapala MA, et al. Adult mouse brain gene expression patterns bear an embryologic imprint. Proc. Natl. Acad. Sci. USA. 2005;102:10357–10362. doi: 10.1073/pnas.0503357102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Kirsch L, Chechik G. On expression patterns and developmental origin of human brain regions. PLoS Comput. Biol. 2016;12:e1005064. doi: 10.1371/journal.pcbi.1005064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Wang DD, Kriegstein AR. Defining the role of GABA in cortical development. J. Physiol. 2009;587:1873–1879. doi: 10.1113/jphysiol.2008.167635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Heck N, et al. GABA-A receptors regulate neocortical neuronal migration in vitro and in vivo. Cereb. Cortex. 2007;17:138–148. doi: 10.1093/cercor/bhj135. [DOI] [PubMed] [Google Scholar]
  • 36.Cuzon Carlson VC, Yeh HH. GABAA receptor subunit profiles of tangentially migrating neurons derived from the medial ganglionic eminence. Cereb. Cortex. 2011;21:1792–1802. doi: 10.1093/cercor/bhq247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Tyzio R, et al. The establishment of GABAergic and glutamatergic synapses on CA1 pyramidal neurons is sequential and correlates with the development of the apical dendrite. J. Neurosci. 1999;19:10372–10382. doi: 10.1523/JNEUROSCI.19-23-10372.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Ben-Ari Y. Excitatory actions of gaba during development: the nature of the nurture. Nat. Rev. Neurosci. 2002;3:728–739. doi: 10.1038/nrn920. [DOI] [PubMed] [Google Scholar]
  • 39.Simeone TA, Donevan SD, Rho JM. Molecular biology and ontogeny of gamma-aminobutyric acid (GABA) receptors in the mammalian central nervous system. J. Child Neurol. 2003;18:39–48. doi: 10.1177/08830738030180012101. [DOI] [PubMed] [Google Scholar]
  • 40.Jimenez D, Lopez-Mascaraque LM, Valverde F, De Carlos JA. Tangential migration in neocortical development. Dev. Biol. 2002;244:155–169. doi: 10.1006/dbio.2002.0586. [DOI] [PubMed] [Google Scholar]
  • 41.Garcia-Moreno F, et al. A neuronal migratory pathway crossing from diencephalon to telencephalon populates amygdala nuclei. Nat. Neurosci. 2010;13:680–689. doi: 10.1038/nn.2556. [DOI] [PubMed] [Google Scholar]
  • 42.Ma T, et al. Subcortical origins of human and monkey neocortical interneurons. Nat. Neurosci. 2013;16:1588–1597. doi: 10.1038/nn.3536. [DOI] [PubMed] [Google Scholar]
  • 43.Nery S, Fishell G, Corbin JG. The caudal ganglionic eminence is a source of distinct cortical and subcortical cell populations. Nat. Neurosci. 2002;5:1279–1287. doi: 10.1038/nn971. [DOI] [PubMed] [Google Scholar]
  • 44.Wu C, Sun D. GABA receptors in brain development, function, and injury. Metab. Brain Dis. 2015;30:367–379. doi: 10.1007/s11011-014-9560-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Letinic K, Zoncu R, Rakic P. Origin of GABAergic neurons in the human neocortex. Nature. 2002;417:645–649. doi: 10.1038/nature00779. [DOI] [PubMed] [Google Scholar]
  • 46.Hernandez-Miranda LR, Parnavelas JG, Chiara F. Molecules and mechanisms involved in the generation and migration of cortical interneurons. ASN Neuro. 2010;2:e00031. doi: 10.1042/AN20090053. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Schuurmans C, Guillemot F. Molecular mechanisms underlying cell fate specification in the developing telencephalon. Curr. Opin. Neurobiol. 2002;12:26–34. doi: 10.1016/S0959-4388(02)00286-6. [DOI] [PubMed] [Google Scholar]
  • 48.Dulcis D, Spitzer NC. Reserve pool neuron transmitter respecification: novel neuroplasticity. Dev. Neurobiol. 2012;72:465–474. doi: 10.1002/dneu.20920. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Mellor JR, Merlo D, Jones A, Wisden W, Randall AD. Mouse cerebellar granule cell differentiation: electrical activity regulates the GABAA receptor alpha 6 subunit gene. J. Neurosci. 1998;18:2822–2833. doi: 10.1523/JNEUROSCI.18-08-02822.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Mulligan MK, et al. Complex control of GABA(A) receptor subunit mRNA expression: variation, covariation, and genetic regulation. PLoS ONE. 2012;7:e34586. doi: 10.1371/journal.pone.0034586. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Benke D, Fritschy JM, Trzeciak A, Bannwarth W, Mohler H. Distribution, prevalence, and drug binding profile of gamma-aminobutyric acid type A receptor subtypes differing in the beta-subunit variant. J. Biol. Chem. 1994;269:27100–27107. [PubMed] [Google Scholar]
  • 52.Sieghart W, Ernst M. Heterogeneity of GABAA receptors: revived interest in the development of subtype-selective drugs. Curr. Med Chem. Cent. Nerv. Syst. Agents. 2005;5:217–242. doi: 10.2174/1568015054863837. [DOI] [Google Scholar]
  • 53.Sieghart W, Sperk G. Subunit composition, distribution and function of GABA(A) receptor subtypes. Curr. Top. Med. Chem. 2002;2:795–816. doi: 10.2174/1568026023393507. [DOI] [PubMed] [Google Scholar]
  • 54.Benke D, et al. Analysis of the presence and abundance of GABAA receptors containing two different types of alpha subunits in murine brain using point-mutated alpha subunits. J. Biol. Chem. 2004;279:43654–43660. doi: 10.1074/jbc.M407154200. [DOI] [PubMed] [Google Scholar]
  • 55.del Rio JC, Araujo F, Ramos B, Ruano D, Vitorica J. Prevalence between different alpha subunits performing the benzodiazepine binding sites in native heterologous GABA(A) receptors containing the alpha2 subunit. J. Neurochem. 2001;79:183–191. doi: 10.1046/j.1471-4159.2001.00551.x. [DOI] [PubMed] [Google Scholar]
  • 56.Duggan MJ, Pollard S, Stephenson FA. Immunoaffinity purification of GABAA receptor alpha-subunit iso-oligomers. Demonstration of receptor populations containing alpha 1 alpha 2, alpha 1 alpha 3, and alpha 2 alpha 3 subunit pairs. J. Biol. Chem. 1991;266:24778–24784. [PubMed] [Google Scholar]
  • 57.Waldvogel HJ, Munkle M, van Roon-Mom W, Mohler H, Faull RLM. The immunohistochemical distribution of the GABAA receptor alpha1, alpha2, alpha3, beta2/3 and gamma2 subunits in the human thalamus. J. Chem. Neuroanat. 2017;82:39–55. doi: 10.1016/j.jchemneu.2017.04.006. [DOI] [PubMed] [Google Scholar]
  • 58.Waldvogel HJ, et al. Differential localization of GABAA receptor subunits within the substantia nigra of the human brain: an immunohistochemical study. J. Comp. Neurol. 2008;506:912–929. doi: 10.1002/cne.21573. [DOI] [PubMed] [Google Scholar]
  • 59.Bonnert TP, et al. theta, a novel gamma-aminobutyric acid type A receptor subunit. Proc. Natl. Acad. Sci. USA. 1999;96:9891–9896. doi: 10.1073/pnas.96.17.9891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Pape JR, et al. Expression of GABA(A) receptor alpha3-, theta-, and epsilon-subunit mRNAs during rat CNS development and immunolocalization of the epsilon subunit in developing postnatal spinal cord. Neuroscience. 2009;160:85–96. doi: 10.1016/j.neuroscience.2009.02.043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Sinkkonen ST, Hanna MC, Kirkness EF, Korpi ER. GABA(A) receptor epsilon and theta subunits display unusual structural variation between species and are enriched in the rat locus ceruleus. J. Neurosci. 2000;20:3588–3595. doi: 10.1523/JNEUROSCI.20-10-03588.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Fowler CD, Liu Y, Wang Z. Estrogen and adult neurogenesis in the amygdala and hypothalamus. Brain Res. Rev. 2008;57:342–351. doi: 10.1016/j.brainresrev.2007.06.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Kokoeva MV, Yin H, Flier JS. Neurogenesis in the hypothalamus of adult mice: potential role in energy balance. Science. 2005;310:679–683. doi: 10.1126/science.1115360. [DOI] [PubMed] [Google Scholar]
  • 64.Sahay A, Hen R. Adult hippocampal neurogenesis in depression. Nat. Neurosci. 2007;10:1110–1115. doi: 10.1038/nn1969. [DOI] [PubMed] [Google Scholar]
  • 65.de Kloet ER, Joels M, Holsboer F. Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci. 2005;6:463–475. doi: 10.1038/nrn1683. [DOI] [PubMed] [Google Scholar]
  • 66.Nestler EJ, et al. Neurobiology of depression. Neuron. 2002;34:13–25. doi: 10.1016/S0896-6273(02)00653-0. [DOI] [PubMed] [Google Scholar]
  • 67.McKee AC, et al. The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy. Acta Neuropathol. 2016;131:75–86. doi: 10.1007/s00401-015-1515-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Nutt DJ, Besson M, Wilson SJ, Dawson GR, Lingford-Hughes AR. Blockade of alcohol’s amnestic activity in humans by an alpha5 subtype benzodiazepine receptor inverse agonist. Neuropharmacology. 2007;53:810–820. doi: 10.1016/j.neuropharm.2007.08.008. [DOI] [PubMed] [Google Scholar]
  • 69.Wegelius K, et al. Distribution of GABA receptor rho subunit transcripts in the rat brain. Eur. J. Neurosci. 1998;10:350–357. doi: 10.1046/j.1460-9568.1998.00023.x. [DOI] [PubMed] [Google Scholar]
  • 70.Boller M, Schmidt M. GABAC receptors in the rat superior colliculus and pretectum participate in synaptic neurotransmission. J. Neurophysiol. 2003;89:2035–2045. doi: 10.1152/jn.00824.2002. [DOI] [PubMed] [Google Scholar]
  • 71.Rosas-Arellano A, Ochoa-de la Paz LD, Miledi R, Martinez-Torres A. Brain distribution and molecular cloning of the bovine GABA rho1 receptor. Neurosci. Res. 2007;57:347–353. doi: 10.1016/j.neures.2006.11.003. [DOI] [PubMed] [Google Scholar]
  • 72.Gonzalez-Gonzalez MA, Gomez-Gonzalez GB, Becerra-Gonzalez M, Martinez-Torres A. Identification of novel cellular clusters define a specialized area in the cerebellar periventricular zone. Sci. Rep. 2017;7:40768. doi: 10.1038/srep40768. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Hedblom E, Kirkness EF. A novel class of GABAA receptor subunit in tissues of the reproductive system. J. Biol. Chem. 1997;272:15346–15350. doi: 10.1074/jbc.272.24.15346. [DOI] [PubMed] [Google Scholar]
  • 74.Petryshen TL, et al. Genetic investigation of chromosome 5q GABAA receptor subunit genes in schizophrenia. Mol. Psychiatry. 2005;10:1074–1088. doi: 10.1038/sj.mp.4001739. [DOI] [PubMed] [Google Scholar]
  • 75.Wang W, Shin Y, Shi M, Kilpatrick DL. Temporal control of a dendritogenesis-linked gene via REST-dependent regulation of nuclear factor I occupancy. Mol. Biol. Cell. 2011;22:868–879. doi: 10.1091/mbc.e10-10-0817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Martenson, J. S., Yamasaki, T., Chaudhury, N. H., Albrecht, D. & Tomita, S. Assembly rules for GABAA receptor complexes in the brain. Elife6, 10.7554/eLife.27443 (2017). [DOI] [PMC free article] [PubMed]
  • 77.Lindemeyer AK, et al. alpha2 Subunit-containing GABAA receptor subtypes are upregulated and contribute to alcohol-induced functional plasticity in the rat hippocampus. Mol. Pharmacol. 2017;92:101–112. doi: 10.1124/mol.116.107797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Roden WH, Peugh LD, Jansen LA. Altered GABA(A) receptor subunit expression and pharmacology in human Angelman syndrome cortex. Neurosci. Lett. 2010;483:167–172. doi: 10.1016/j.neulet.2010.08.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Shirkhorshidi AS, Aghabozorgi S, Wah TY. A comparison study on similarity and dissimilarity measures in clustering continuous data. PLoS ONE. 2015;10:e0144059. doi: 10.1371/journal.pone.0144059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Szekely GJ, Rizzo ML, Bakirov NK. Measuring and testing dependence by correlation of distances. Ann. Stat. 2007;35:2769–2794. doi: 10.1214/009053607000000505. [DOI] [Google Scholar]
  • 81.Gold SJ, Ambros-Ingerson J, Horowitz JR, Lynch G, Gall CM. Stoichiometries of AMPA receptor subunit mRNAs in rat brain fall into discrete categories. J. Comp. Neurol. 1997;385:491–502. doi: 10.1002/(SICI)1096-9861(19970908)385:4&#x0003c;491::AID-CNE1&#x0003e;3.0.CO;2-Z. [DOI] [PubMed] [Google Scholar]
  • 82.Horn D, Gottlieb A. Algorithm for data clustering in pattern recognition problems based on quantum mechanics. Phys. Rev. Lett. 2002;88:018702. doi: 10.1103/PhysRevLett.88.018702. [DOI] [PubMed] [Google Scholar]
  • 83.Dhillon, I. S. Co-clustering documents and words using bipartite spectral graph partitioning. KDD ’01 Proc. Seventh ACM SIGKDD International Conference on Knowledge Discovery and Data Mining 269–274 (ACM Press, New York NY, 2001).
  • 84.Deutsch L, Horn D. The weight-shape decomposition of density estimates: a framework for clustering and image analysis algorithms. Pattern Recogn. 2018;81:190–199. doi: 10.1016/j.patcog.2018.03.034. [DOI] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Data 1 (10.5KB, xlsx)
Supplementary Data 2 (14.5KB, xlsx)
Supplementary Data 3 (18.3KB, xlsx)
Supplementary Data 4 (19.9KB, xlsx)
Supplementary Data 5 (18.5KB, xlsx)
Supplementary Data 6 (108.8KB, xlsx)
Supplementary Data 7 (14.9KB, xlsx)
Supplementary Data 8 (47.9KB, xlsx)
Supplementary Data 9 (11.4KB, xlsx)
Supplementary Data 10 (3.8MB, xlsx)
42003_2019_413_MOESM11_ESM.pdf (71.6KB, pdf)

Description of Additional Supplementary Files

Supplementary Material (3.3MB, pdf)
Reporting Summary (69.5KB, pdf)

Data Availability Statement

Microarray and RNA sequence data that support the findings of this study are available from the Allen Institute: http://human.brain-map.org, http://aging.brain-map.org/download/index, and http://celltypes.brain-map.org/rnaseq. Additional data used for the figures are provided in Supplementary Data 10.

All codes used in this work have been previously published and are publicly available. A pipeline of the analysis for fast implementation can be provided upon request.


Articles from Communications Biology are provided here courtesy of Nature Publishing Group

RESOURCES